Login
$CUE
$13.80 -$0.30 (2.13%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Shao-Lee Lin Also a director
Chief Executive Officer
Title from the Form 4 dated Oct 12, 2026
Not stated Not stated Not reported
James Ahlers
Chief Financial Officer
Title from the Form 8-K dated Jul 30, 2026
Not stated Not stated Not reported
Daniel G. Baker
Interim Chief Development Officer
75 Since 2024
2 years
Not reported
Sumita Ray
Chief Legal Compliance Officer
Title from the Form 4 dated Oct 12, 2026
Not stated Not stated Not reported
Dominique Christian Borie
Chief Medical Officer
Title from the Form 4 dated Jul 13, 2026
Not stated Not stated Not reported
Colin G. Sandercock
Senior Vice President, Intellectual Property
69 Not stated $599,222
Michael Meluzio
VP, Prin. Accounting Officer
Title from the Form 4 dated Oct 12, 2026
Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Mar 16, 2026 · updated by the 8-Ks of May 1, 2026 and Jun 2, 2026

Directors
5
serving now
Average tenure
2.0 years
from year joined
CEO also chairs the board
No
Pasha Sarraf
Director Age On board Committees Other public boards 2025 pay Source
Pasha Sarraf
56 2025
1 year
None stated PolarityBio, Praesidia Biotherapeutics $88,080
Shao-Lee Lin Joined Apr 30, 2026
- - - - Paid as CEO
Pamela D. Garzone
71 2023
3 years
Compensation Committee
None stated $69,381
Daniel Camardo Joined May 30, 2026
- -
Nominating and Corporate Governance Committee · Chair Audit Committee
- -
Viola Meehan Joined May 30, 2026
- -
Audit Committee · Chair Compensation Committee
- -
Nominated to join at the meeting
Not on the board yet; they join only if elected.

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

3 disclosed in the proxy filed Mar 16, 2026
Affiliates of Bleichroeder LP
holder of more than 5% of our voting securities
$ 2,497,036
September 2024

Purchased shares and warrants in the September 2024 underwritten public offering

Affiliates of Bleichroeder LP
holder of more than 5% of our voting securities
$ 2,498,657
April 2025

Purchased shares and warrants in the April 2025 underwritten public offering

Affiliates of Bleichroeder LP
holder of more than 5% of our voting securities
$ 1,000,001
December 22, 2025

Purchased warrants in the December 2025 underwritten public offering

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support